Software providing personalized ESA dosing increased the rate of target hemoglobin attainment compared with standard of care in patients with hemoglobin variability while on dialysis. Individualizing ...
In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, we enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results